Exercise Therapy for Women With ANOCA (ANOCA Exercise)
Exercise Therapy for Women With ANOCA: a Randomised, Controlled Trial
Angina is a feeling of chest pain or discomfort which can happen if there is reduced blood flow to the heart. Patients can experience angina with no obstructive coronary arteries (ANOCA) which is a difficult condition to treat (ie relieve angina) since few randomised, controlled therapy trials have been undertaken for ANOCA. Until now, angina has been mainly studied in men even though women are at least two-fold more likely than men to experience ANOCA.
In 2023, a Scientific Statement from the American Heart Association affirmed that resistance exercise training can improve or maintain muscle mass and strength and confer favourable physiological and clinical effects on cardiovascular disease and risk factors. Resistance exercise has not been assessed in ANOCA and it offers an important opportunity to study non drug alternatives to treatment for women.
This study will use a resistance based exercise programme to investigate if symptoms of ANOCA can be improved in women. It will recruit at least 76 patients (maximum 152 patients) across 13 hospitals in the UK and the Netherlands.
The study will use a randomised wait list control design. This means all participants will be offered the intervention, but the randomisation will decide when they undergo it.
It is part of a platform of trials for women with ANOCA. We are also setting up a drug study called ANOCA Therapy and a cohort study called ANOCA- Diagnosis.
Przegląd badań
Status
Status
Warunki
Warunki
Interwencja / Leczenie
Interwencja / Leczenie
Szczegółowy opis
There is a gap in knowledge on evidence-based therapy for ANOCA. Stratified medicine is a population-level diagnostic approach for identifying endotypes in a heterogenous population of all-comers. An endotype is defined as a subtype of a condition, which must be characterised by a distinct functional or pathophysiological mechanism.
Use of quantitative noninvasive and invasive diagnostic methods, such as magnetic resonance imaging and coronary function tests involving acetylcholine testing, enables more accurate identification and discrimination of causal endotypes of ANOCA. This is especially relevant for women with ANOCA who have historically been under-recognised.
Quantitative diagnostic methods should bring an end to empirical therapy, therapeutic nihilism and sex disparities in ANOCA.
Precision medicine is different. Precision medicine targets the individual (and their endotype) with a mechanism informed therapy. Accordingly, in this Wellcome Leap Visible project, we will employ a stratified medicine diagnostic approach in women with suspected ANOCA undergoing invasive CFTs in multiple hospitals and then employ a precision medicine strategy by offering each woman an endotype-informed therapy option.
Resistance exercise has not been previously investigated in ANOCA and it therefore represents a novel therapeutic option. This lifestyle intervention will increase the range of trial options, maximize patient choice for participation, and facilitate timely delivery of this project. The beneficial effects of resistance exercise on cardiovascular function have recently been endorsed in a Scientific Statement from the American Heart Association and further supported by a systematic review and favourable experience in our recent randomized trial in Long COVID.
In 2023, a Scientific Statement from the American Heart Association affirmed that resistance exercise training can improve or maintain muscle mass and strength and confer favourable physiological and clinical effects on cardiovascular disease and risk factors. In 19 men with coronary artery disease and endothelial dysfunction, indicated by abnormal acetylcholine-induced coronary vasoconstriction, a randomized controlled trial of aerobic exercise training demonstrated improvements in endothelium-dependent vasodilatation both in epicardial coronary vessels and in resistance vessels. The intervention involved an exercise program six times per day for at least 10 minutes. These results were promising but came with major limitations: no women were included in the study and the exercise program is both burdensome and impractical.
Resistance exercise has not been assessed in ANOCA. Inclusion of a non-CTIMP (lifestyle intervention) brings strategic advantages to our ANOCA platform. A non-medicinal intervention provides an accessible therapy option for women of child-bearing age and for those who may prefer not to participate in an investigational drug trial. This non-CTIMP may also become an option for women who withdraw from a CTIMP, or who complete a CTIMP and are willing to continue into a second trial. The basket trial of resistance exercise may include participants who have completed a precision medicine CTIMP who then wish to participate in the resistance exercise trial or vice versa.
Typ studiów
Typ studiów
Zapisy (Szacowany)
Zapisy
Faza
Faza
- Nie dotyczy
Kontakty i lokalizacje
Kontakt w sprawie studiów
Kontakt w sprawie studiów
- Nazwa: Clare Dolan
- Numer telefonu: 0141 314 4328
- E-mail: clare.dolan3@nhs.scot
Kopia zapasowa kontaktu do badania
- Nazwa: PMU Mail box
- Numer telefonu: 0141 314 4328
- E-mail: ggc.pmu.research@nhs.scot
Lokalizacje studiów
-
-
-
Basildon, Zjednoczone Królestwo
- Basildon University Hospital
-
Bath, Zjednoczone Królestwo
- Royal United Hospital Bath
-
Cambridge, Zjednoczone Królestwo
- Royal Papworth Hospital
-
Glasgow, Zjednoczone Królestwo, G51 4TF
- Queen Elizabeth University Hospital Clinical Research Facility
-
Kontakt:
- Colin Berry
- Numer telefonu: 0141 232 7600
- E-mail: Colin.Berry@glasgow.ac.uk
-
Leeds, Zjednoczone Królestwo
- Leeds General Infirmary
-
London, Zjednoczone Królestwo
- Kings College Hospital
-
London, Zjednoczone Królestwo
- Brompton Hospital
-
London, Zjednoczone Królestwo
- Guy and St Thomas Hospital
-
Newcastle upon Tyne, Zjednoczone Królestwo
- Freeman Hospital
-
Kontakt:
- Vijay Kunadian
-
Nottingham, Zjednoczone Królestwo
- Nottingham City Hospital
-
Sunderland, Zjednoczone Królestwo
- Sunderland Royal Hospital
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Kryteria kwalifikacji
Wiek uprawniający do nauki
- Dorosły
- Starszy dorosły
Akceptuje zdrowych ochotników
Opis
Inclusion Criteria:
- Angina with no obstructive coronary arties (ANOCA)
- Myocardial perfusion reserve or coronary flow reserve recorded within three years
- Seattle Angina Questionnaire frequency score ≤60
- Duke Activity Status Index ≤34
- Female sex
Exclusion Criteria:
- Age <18 years
- Unable to provide informed consent
- - Unable to comply with the protocol
- Pregnancy
- Currently undertaking resistance exercise activities
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Brak (otwarta etykieta)
Liczba ramion
Broń i interwencje
Grupa uczestników / ArmGrupa uczestników / Arm |
Interwencja / LeczenieInterwencja / Leczenie |
|---|---|
|
Eksperymentalny: Intervention
Allocated to exercise intervention first
|
Participants will undergo daily resistance based exercise for 8 weeks
|
|
Aktywny komparator: Control
Allocated to exercise intervention second
|
Participants will undergo daily resistance based exercise for 8 weeks
|
Co mierzy badanie?
Podstawowe miary wyniku
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Seattle Angina Questionnaire
Ramy czasowe: Change from Baseline to Week 9
|
The Seattle Angina Questionnaire a validated 19-item patient-reported survey used to measure coronary artery disease and angina treatment efficacy.
Patients will complete on paper or electronically.
The scores range from 0 to 100, with higher scores indicating less frequent angina, improved function, and better quality of life.
|
Change from Baseline to Week 9
|
Miary wyników drugorzędnych
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Myocardial perfusion reserve (MPR)
Ramy czasowe: Change from baseline to week 9
|
The ratio of maximum blood flow in the heart muscle under stress compared to resting flow
|
Change from baseline to week 9
|
|
Handgrip strength using hand dynamometer
Ramy czasowe: Change from baseline to week 9
|
Measured in Kgs.
This is used as a proxy for overall body strength with lower measures indicating less strength.
|
Change from baseline to week 9
|
|
Short Physical Performance Battery (SPPB)
Ramy czasowe: Change from baseline to week 9
|
Used as a proxy for fitness
|
Change from baseline to week 9
|
|
Brief Illness perception Questionnaire (Brief IPQ)
Ramy czasowe: Change from baseline to week 9
|
A nine-item scale designed to rapidly assess the cognitive and emotional representations of illness.
It consists of 9 items: 8 are scored on a 0-10 scale, and item 9 is an open-ended question assessing perceived causes.
The total score (0-80) is calculated by summing the first 8 items, with items 3, 4, and 7 reverse scored.
Higher scores generally reflect a more threatening perception of the illness
|
Change from baseline to week 9
|
|
Patient Health Questionnaire-4 of (PHQ4)
Ramy czasowe: Change from Baseline to Week 9
|
An ultra-brief screening tool used to assess core symptoms of anxiety and depression.
Higher scores indicate greater feelings of anxiety and depression.
|
Change from Baseline to Week 9
|
|
Duke Activity Status Index (DASI)
Ramy czasowe: From Baseline to Week 9
|
A 12-item, self-administered questionnaire used to estimate a patient's functional capacity and peak oxygen uptake.
Scores range from 0 to 58.2, with higher scores indicating better physical fitness and lower risk
|
From Baseline to Week 9
|
|
EQ-5D (EQ-5D-5L)
Ramy czasowe: Change from Baseline to Week 9
|
The EQ-5D evaluates health across 5 domains (mobility, self-care, usual activities, pain/discomfort, anxiety/depression). It yields three metrics: a 5-digit health profile string, a weighted index value, and a 0-100 self-rated Visual Analogue Scale (VAS) score. For the 5-digit health profile string higher individual numbers indicate worse health problems. For the weighted index value a score of 1 indicates perfect health, while 0 represents death. For the visual analogue score higher numbers here indicate better health |
Change from Baseline to Week 9
|
|
International Physical Activity Questionnaire (IPAQ)
Ramy czasowe: Change from Baseline to Week 9
|
Used to obtain comparable estimates of physical activity between populations and countries.
Higher scores indicate greater physical activity.
|
Change from Baseline to Week 9
|
|
Fatigue severity scale questionnaire
Ramy czasowe: Change from Baseline to Week 9
|
Rates level of fatigue.
9 statements assess how fatigue impacts daily life.
Each statement is rated on a 7-point Likert scale, ranging from 1 (strongly disagree) to 7 (strongly agree).
Higher scores indicate greater fatigue.
|
Change from Baseline to Week 9
|
|
Short Form Post-Exercise Malaise Questionnaire
Ramy czasowe: Change from Baseline to Week 9
|
measures symptom exacerbation by assessing frequency and severity of symptoms.
Higher scores reflect a stronger indication of post exercise malaise.
|
Change from Baseline to Week 9
|
|
Episodes of care (primary, secondary, physiotherapy, rehabilitation)
Ramy czasowe: Week 9
|
How many times participants engaged with services
|
Week 9
|
|
Hospitalisation for any reason by electronic health record review (where available) up to 4 months (Visit 3)
Ramy czasowe: Week 17
|
Review of medical notes to see if the patient has been in hospital
|
Week 17
|
Współpracownicy i badacze
Sponsor
Sponsor
Współpracownicy
Współpracownicy
Śledczy
Śledczy
- Główny śledczy: Colin Berry, The University of Glasgow
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Szacowany)
Rozpoczęcie studiów
Zakończenie podstawowe (Szacowany)
Zakończenie podstawowe
Ukończenie studiów (Szacowany)
Ukończenie studiów
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Pierwszy wysłany
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia wysłana aktualizacja
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
Inne numery identyfikacyjne badania
- GN26CA170
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Opis planu IPD
Ramy czasowe udostępniania IPD
Kryteria dostępu do udostępniania IPD
Typ informacji pomocniczych dotyczących udostępniania IPD
- PROTOKÓŁ BADANIA
- SOK ROŚLINNY
- ICF
- CSR
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .